Figure 3. Effects of FA on MEK and ERK1/2 activation.
(A) FA treatment (0–50 μM) dose dependently induced the activation of ERK1/2. (B) FA treatment (20 μM) time dependently induced the activation of ERK1/2. (C) FA treatment (0–50 μM) dose dependently induced the activation of MEK. (D) FA treatment (20 μM) time dependently induced the activation of MEK.